SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Approval of US Pilot Clinical Trial to Evaluate AclarusDx(™), the ExonHit Therapeutics Inc. Investigational Test for Alzheimer’s Disease Diagnosis